Clinical characteristics and vaccine effectiveness against SARS-CoV-2 Omicron subvariant BA.2 in the children

Clinical characteristics and vaccine effectiveness against SARS-CoV-2 Omicron subvariant BA.2 in the children

Bibliographic Details
Main Authors:	Xiaohe Li, Liwen Wu, Youzhi Qu, Mengli Cao, Jiaqi Feng, Hua Huang, Yi Liu, Hongzhou Lu, Quanying Liu, Yingxia Liu
Format:	Article
Language:	English
Published:	Nature Publishing Group 2022-06-01
Series:	Signal Transduction and Targeted Therapy
Online Access:	https://doi.org/10.1038/s41392-022-01023-w

Similar Items

Vitamin D levels and clinical outcomes of SARS-CoV-2 Omicron subvariant BA.2 in children: A longitudinal cohort study
by: Denggao Peng, et al.
Published: (2022-07-01)

Research of Epidemiologic Feature and Control of SARS-CoV-2 Omicron Subvariants BA.4 and BA.5
by: Yu WU, Jue LIU, Min LIU, Wannian LIANG
Published: (2022-10-01)

Antigenic characterization of SARS-CoV-2 Omicron subvariant BA.4.6
by: Aiste Dijokaite-Guraliuc, et al.
Published: (2022-11-01)

Epidemiology and analysis of SARS-CoV-2 Omicron subvariants BA.1 and 2 in Taiwan
by: Li-Teh Liu, et al.
Published: (2023-10-01)

Comparative pathogenicity of SARS-CoV-2 Omicron subvariants including BA.1, BA.2, and BA.5
by: Tomokazu Tamura, et al.
Published: (2023-07-01)

Duration of mRNA vaccine protection against SARS-CoV-2 Omicron BA.1 and BA.2 subvariants in Qatar
by: Hiam Chemaitelly, et al.
Published: (2022-06-01)

Limited neutralisation of the SARS-CoV-2 Omicron subvariants BA.1 and BA.2 by convalescent and vaccine serum and monoclonal antibodies
by: Alexander Wilhelm, et al.
Published: (2022-08-01)

Household transmission of SARS-CoV-2 Omicron variant of concern subvariants BA.1 and BA.2 in Denmark
by: Frederik Plesner Lyngse, et al.
Published: (2022-09-01)

SARS-CoV-2 Omicron subvariant BA.2.86: limited potential for global spread
by: Xinling Wang, et al.
Published: (2023-11-01)

Immunogenicity and efficacy of vaccine boosters against SARS-CoV-2 Omicron subvariant BA.5 in male Syrian hamsters
by: Rafael R. G. Machado, et al.
Published: (2023-07-01)

An imported human case with the SARS-CoV-2 Omicron subvariant BA.2.75 in Yunnan Province, China
by: Meiling Zhang, et al.
Published: (2022-12-01)

Immune Evasion of SARS-CoV-2 Omicron Subvariants
by: Hanzhong Ke, et al.
Published: (2022-09-01)

Effectiveness of mRNA-1273 vaccination against SARS-CoV-2 omicron subvariants BA.1, BA.2, BA.2.12.1, BA.4, and BA.5
by: Hung Fu Tseng, et al.
Published: (2023-01-01)

Case Report: Omicron BA.2 Subvariant of SARS-CoV-2 Outcompetes BA.1 in Two Co-infection Cases
by: Marija Gjorgjievska, et al.
Published: (2022-04-01)

Strong attenuation of SARS-CoV-2 Omicron BA.1 and increased replication of the BA.5 subvariant in human cardiomyocytes
by: Rayhane Nchioua, et al.
Published: (2022-12-01)

Comparative neutralization profiles of naive and breakthrough infections with Delta, Omicron BA.1 and BA.2 variants of SARS-CoV-2
by: Yang Yang, et al.
Published: (2022-09-01)

Genomic architecture and evolutionary relationship of BA.2.75: A Centaurus subvariant of Omicron SARS-CoV-2.
by: Atia Basheer, et al.
Published: (2023-01-01)

Severity of SARS-CoV-2 Omicron XBB subvariants in Singapore
by: Rachael Pung, et al.
Published: (2023-08-01)

The rising concern of the SARS-CoV-2 omicron subvariants and their hybrids
by: H Shafeeq Ahmed
Published: (2022-01-01)

Reinfections with Different SARS-CoV-2 Omicron Subvariants, France
by: Nhu Ngoc Nguyen, et al.
Published: (2022-11-01)

The Omicron BA.2.2.1 subvariant drove the wave of SARS-CoV-2 outbreak in Shanghai during spring 2022
by: Yun Ling, et al.
Published: (2022-09-01)

The Epidemiological Features of the SARS-CoV-2 Omicron Subvariant BA.5 and Its Evasion of the Neutralizing Activity of Vaccination and Prior Infection
by: Dandan Tian, et al.
Published: (2022-10-01)

Clinical Efficacy of the Neutralizing Antibody Therapy Sotrovimab in Patients with SARS-CoV-2 Omicron BA.1 and BA.2 Subvariant Infections
by: Naoyuki Miyashita, et al.
Published: (2023-05-01)

Clinical characteristics of liver injury in SARS-CoV-2 Omicron variant- and Omicron subvariant-infected patients
by: Haohui Deng, et al.
Published: (2023-01-01)

Broadly neutralizing and protective nanobodies against SARS-CoV-2 Omicron subvariants BA.1, BA.2, and BA.4/5 and diverse sarbecoviruses
by: Mingxi Li, et al.
Published: (2022-12-01)

Comparison of the replication and neutralization of different SARS‐CoV‐2 Omicron subvariants in vitro
by: Yaqing Zhang, et al.
Published: (2023-02-01)

Evolutionary characteristics of SARS-CoV-2 Omicron subvariants adapted to the host
by: Haijun Tang, et al.
Published: (2023-05-01)

As the SARS-CoV-2 virus evolves, should Omicron subvariant BA.2 be subjected to quarantine, or should we learn to live with it?
by: Ren Xu, et al.
Published: (2022-11-01)

Neutralizing Antibodies against the SARS-CoV-2 Ancestral Strain and Omicron BA.1 Subvariant in Dogs and Cats in Mexico
by: Freddy Dehesa-Canseco, et al.
Published: (2023-06-01)

SARS-CoV-2 vaccination of convalescents boosts neutralization capacity against Omicron subvariants BA.1, BA.2 and BA.5 and can be predicted by anti-S antibody concentrations in serological assays
by: Alina Seidel, et al.
Published: (2023-04-01)

Effects of tea, catechins and catechin derivatives on Omicron subvariants of SARS-CoV-2
by: Masaharu Shin-Ya, et al.
Published: (2023-10-01)

Broadly neutralizing human antibodies against Omicron subvariants of SARS-CoV-2
by: Hsiao-Ling Chiang, et al.
Published: (2023-07-01)

High Transmission Rates of Early Omicron Subvariant BA.2 in Bangkok, Thailand
by: Sininat Petcharat, et al.
Published: (2023-01-01)

Epidemiological and clinical features of children with the Omicron BA.5.2 subvariant in Guangzhou
by: Feng Li, et al.
Published: (2023-04-01)

Evolution and neutralization escape of the SARS-CoV-2 BA.2.86 subvariant
by: Khadija Khan, et al.
Published: (2023-12-01)

Mapping the Early Dispersal Patterns of SARS-CoV-2 Omicron BA.4 and BA.5 Subvariants in the Absence of Travel Restrictions and Testing at the Borders in Europe
by: Evangelia Georgia Kostaki, et al.
Published: (2022-12-01)

Omicron subvariant BA.5 efficiently infects lung cells
by: Markus Hoffmann, et al.
Published: (2023-06-01)

XBB.1.5: A new threatening SARS-CoV-2 Omicron subvariant
by: Md. Aminul Islam, et al.
Published: (2023-04-01)

Analyzing the emerging patterns of SARS‐CoV‐2 Omicron subvariants for the development of next‐gen vaccine: An observational study
by: Ranjan K. Mohapatra, et al.
Published: (2023-10-01)

Efficacy of sotrovimab on omicron BA.2, BA.4 and BA.5 subvariants of sars-cov-2 vs. other early therapies: a systematic review and meta-analysis of literature data
by: Antonio Russo, et al.
Published: (2024-01-01)